• 15553 Citations
  • 64 Scopus h-Index
1975 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ian D Hay is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Thyroid Neoplasms Medicine & Life Sciences
Thyroid Gland Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Follicular Adenocarcinoma Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Thyrotropin Medicine & Life Sciences
Papillary Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1975 2018

Management of Papillary Thyroid Microcarcinoma

Brito Campana, J. & Hay, I. D., Jan 1 2018, (Accepted/In press) In : Endocrinology and Metabolism Clinics of North America.

Research output: Contribution to journalArticle

Thyroid Neoplasms
Patient Preference
Decision Making
Thyroid Gland
Incidence
12 Citations (Scopus)

Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936–2015)

Hay, I. D., Johnson, T. R., Kaggal, S., Reinalda, M. S., Iniguez-Ariza, N. M., Grant, C. S., Pittock, S. T. & Thompson, G. B., Oct 13 2017, (Accepted/In press) In : World Journal of Surgery. p. 1-14 14 p.

Research output: Contribution to journalArticle

Mortality
Recurrence
Neoplasm Metastasis
Neoplasms
Papillary Thyroid cancer

Role of radioactive iodine for remnant ablation in patients with papillary thyroid cancer

Iniguez-Ariza, N. M., Kaggal, S. & Hay, I. D., Jun 24 2017, Management of Differentiated Thyroid Cancer. Springer International Publishing, p. 205-222 18 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Iodine
Papillary Thyroid cancer
17 Citations (Scopus)

Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer

Prasongsook, N., Kumar, A., Chintakuntlawar, A., Foote, R. L., Kasperbauer, J., Molina, J. R., Garces, Y. I., Ma, D., Wittich, M. A. N., Rubin, J., Richardson, R., Morris, J., Hay, I. D., Fatourechi, V., McIver, B., Ryder, M., Thompson, G., Grant, C., Richards, M., Sebo, T. J. & 5 others, Rivera, M., Suman, V. J., Jenkins, S. M., Smallridge, R. C. & Bible, K. C., Dec 1 2017, In : The Journal of clinical endocrinology and metabolism. 102, 12, p. 4506-4514 9 p.

Research output: Contribution to journalArticle

Hazards
Survival
Palliative Care
Confidence Intervals
Therapeutics
6 Citations (Scopus)

Thyroid cancer: Overdiagnosis of papillary carcinoma — who benefits?

Brito Campana, J. & Hay, I. D., Jan 6 2017, (Accepted/In press) In : Nature Reviews Endocrinology.

Research output: Contribution to journalArticle

Papillary Carcinoma
Thyroid Neoplasms
Medical Overuse